First-of-its-kind flu vaccine could be coming as FDA panel weighs historic shot

Moderna is seeking Food and Drug Administration approval of its new shot, dubbed mFlusiva, as an option for people 50 and older.

The FDA advisory committee meeting is a step toward a final decision ahead of the winter flu season. ...